Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The document concludes that more research is needed to fully understand the causes of PCOS.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

ADAM 10 and ADAM 12 proteins are involved in different stages of hair growth and could be targets for treating hair disorders.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair follicle culture helps study hair growth but has limitations in modeling the full hair cycle.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.